痴呆症患者是如何遭受的?
1University of Pennsylvania, Philadelphia, PA, USA.
概括
痴呆症患者的痛苦是照顾者客观地观察到的,不仅仅取决于患者的自我报告. 成功的照顾者支持促进了幸福感,而它的缺失导致了痛苦.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 思想的哲学 思想的哲学
背景情况:
- 痴呆症护理在评估患者福祉方面存在挑战.
- 患者的自我报告可能无法完全捕捉患有痴呆症的经历.
研究的目的:
- 提出一个客观的框架来理解痴呆症患者的痛苦.
- 探索护理人员观察在识别痴呆相关痛苦中的作用.
主要方法:
- 哲学论证和概念分析.
- 检查护理人员在感知和支持痴呆症患者认知和情绪状态方面的作用.
主要成果:
- 患有痴呆症是其他人可以知道的,独立于患者的陈述.
- 护理人员的观察是识别痛苦的关键组成部分.
- 成功的精神支持照顾创造了"在家里的感觉",减少了痛苦.
结论:
- 通过护理人员的观察,可以客观地解释患有痴呆症的情况.
- 心理支持护理的质量直接影响痛苦的存在或不存在.
- 这种观点将痛苦重新定义为痴呆症护理中可观察到的现象.
相关概念视频
Dementia
91
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
91
Alzheimer's Disease: Overview
429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
Cognitive Development During Adulthood
45
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
45
Alzheimer's Disease: Treatment
150
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
150
Intellectual Disability
35
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
35
Parkinson's Disease: Overview
429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429


